Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives

por Sener, Ugur, Ruff, Michael W., Campian, Jian L.
Publicado 2022

Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide

por Khaddour, Karam, Harrison, Nigel, Govindan, Ashwin, Campian, Jian L.
Publicado 2020

LOCL-07 LOCO-REGIONAL INFUSION OF GB-13 (IL13.E13K-PE4E) AS A POTENTIALLY PROMISING TREATMENT FOR RECURRENT HIGH-GRADE GLIOMA

por Rechberger, Julian, Khatua, Soumen, Campian, Jian, Sarkaria, Jann, Schwartz, Jonathan, Daniels, David, Schrecengost, Randy
Publicado 2022

Pituitary carcinoma: Two case reports and review of literature

por Xu, Lai, Khaddour, Karam, Chen, Jie, Rich, Keith M, Perrin, Richard J, Campian, Jian Li
Publicado 2020

Proton craniospinal irradiation with bevacizumab and pembrolizumab for leptomeningeal disease: a case report

por Webb, Mason J, Breen, William G, Laack, Nadia N, Leventakos, Konstantinos, Campian, Jian L, Sener, Ugur
Publicado 2023

The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma

por Xi, Jing, Hassan, Bilal, Katumba, Ruth G. N., Khaddour, Karam, Govindan, Akshay, Luo, Jingqin, Huang, Jiayi, Campian, Jian L.
Publicado 2021

CLRM-10. THE INTER-RELATIONSHIP BETWEEN MULTI-MODAL LONGITUDINAL BIOMARKERS OF NEURAL DAMAGE, INFLAMMATION, AND COGNITION AFTER CAR T CELLULAR THERAPY: A SINGLE-CENTER PROSPECTIVE...

por Butt, Omar, Zhou, Alice, Lee, Ken, Wu, Gregory, Song, Sheng-Kwei, Campian, Jian, DiPersio, John, Ances, Beau, Ghobadi, Armin
Publicado 2021

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma

por Ma, Sirui, Rudra, Soumon, Campian, Jian L, Dahiya, Sonika, Dunn, Gavin P, Johanns, Tanner, Goldstein, Michael, Kim, Albert H, Huang, Jiayi
Publicado 2020

Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study

por Damato, Anna R, Luo, Jingqin, Katumba, Ruth G N, Talcott, Grayson R, Rubin, Joshua B, Herzog, Erik D, Campian, Jian L
Publicado 2021

Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier

por Leuthardt, Eric C., Duan, Chong, Kim, Michael J., Campian, Jian L., Kim, Albert H., Miller-Thomas, Michelle M., Shimony, Joshua S., Tran, David D.
Publicado 2016

Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab

por Hwang, Helen, Huang, Jiayi, Khaddour, Karam, Butt, Omar H, Ansstas, George, Chen, Jie, Katumba, Ruth GN, Kim, Albert H, Leuthardt, Eric C, Campian, Jian L
Publicado 2022

Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma

por Ma, Sirui, Rudra, Soumon, Campian, Jian L, Chheda, Milan G, Johanns, Tanner M, Ansstas, George, Abraham, Christopher D, Chicoine, Michael R, Leuthardt, Eric C, Dowling, Joshua L, Dunn, Gavin P, Kim, Albert H, Huang, Jiayi
Publicado 2021

Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry

por Galdieri, Luciano, Jash, Arijita, Malkova, Olga, Mao, Diane D., DeSouza, Patrick, Chu, Yunli E., Salter, Amber, Campian, Jian L., Naegle, Kristen M., Brennan, Cameron W., Wakimoto, Hiroaki, Oh, Stephen T., Kim, Albert H., Chheda, Milan G.
Publicado 2021

A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)

por Cloughesy, Timothy F, Brenner, Andrew, de Groot, John F, Butowski, Nicholas A, Zach, Leor, Campian, Jian L, Ellingson, Benjamin M, Freedman, Laurence S, Cohen, Yael C, Lowenton-Spier, Noa, Rachmilewitz Minei, Tamar, Fain Shmueli, Shifra, Wen, Patrick Y
Publicado 2020

Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)

por Galanis, Evanthia, Anderson, S Keith, Twohy, Erin, Butowski, Nicholas A, Hormigo, Adilia, Schiff, David, Omuro, Antonio, Jaeckle, Kurt A, Kumar, Shaji, Kaufmann, Timothy J, Geyer, Susan, Kumthekar, Priya U, Campian, Jian, Giannini, Caterina, Buckner, Jan C, Wen, Patrick Y
Publicado 2022

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma

por Plotkin, Scott R, Allen, Jeffrey, Dhall, Girish, Campian, Jian L, Clapp, D Wade, Fisher, Michael J, Jain, Rakesh K, Tonsgard, James, Ullrich, Nicole J, Thomas, Coretta, Edwards, Lloyd J, Korf, Bruce, Packer, Roger, Karajannis, Matthias A, Blakeley, Jaishri O
Publicado 2023

A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma

por Butt, Omar H, Zhou, Alice Y, Huang, Jiayi, Leidig, William A, Silberstein, Alice E, Chheda, Milan G, Johanns, Tanner M, Ansstas, George, Liu, Jingxia, Talcott, Grayson, Nakiwala, Ruth, Shimony, Joshua S, Kim, Albert H, Leuthardt, Eric C, Tran, David D, Campian, Jian L
Publicado 2021

Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma

por Butt, Omar H, Zhou, Alice Y, Huang, Jiayi, Leidig, William A, Silberstein, Alice E, Chheda, Milan G, Johanns, Tanner M, Ansstas, George, Liu, Jingxia, Talcott, Grayson, Nakiwala, Ruth, Shimony, Joshua S, Kim, Albert H, Leuthardt, Eric C, Tran, David D, Campian, Jian L
Publicado 2022

Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell–Associated Neurotoxicity Syndrome

por Butt, Omar H., Zhou, Alice Y., Caimi, Paolo F., Luckett, Patrick H., Wisch, Julie K., Derenoncourt, Paul-Robert, Lee, Kenneth, Wu, Gregory F., de Lima, Marcos J. G., Campian, Jian L., Frank, Matthew J., DiPersio, John F., Ghobadi, Armin, Ances, Beau M.
Publicado 2022

Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma

por Ellingson, Benjamin M, Patel, Kunal, Wang, Chencai, Raymond, Catalina, Brenner, Andrew, de Groot, John F, Butowski, Nicholas A, Zach, Leor, Campian, Jian L, Schlossman, Jacob, Rizvi, Shan, Cohen, Yael C, Lowenton-Spier, Noa, Minei, Tamar Rachmilewitz, Shmueli, Shifra Fain, Wen, Patrick Y, Cloughesy, Timothy F
Publicado 2021